GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » Short-Term Capital Lease Obligation

Itonis (Itonis) Short-Term Capital Lease Obligation : $0.00 Mil (As of Feb. 2008)


View and export this data going back to 2007. Start your Free Trial

What is Itonis Short-Term Capital Lease Obligation?

Itonis's Short-Term Capital Lease Obligation for the quarter that ended in Feb. 2008 was $0.00 Mil.


Itonis Short-Term Capital Lease Obligation Historical Data

The historical data trend for Itonis's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis Short-Term Capital Lease Obligation Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
Short-Term Capital Lease Obligation
- - -

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Itonis Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Itonis Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Itonis's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Itonis (Itonis) Business Description

Industry
Traded in Other Exchanges
N/A
Address
22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines